Release Date: 25/07/14 19:04 Summary: Quarterly Activities Report Price Sensitive: Yes Download Document 910.61KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%